Anxiety Disorders Completed Phase 4 Trials for Quetiapine (DB01224)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00352469Trial of Seroquel SR for Alcohol Dependence and Comorbid AnxietyTreatment
NCT00113295Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety DisorderTreatment